Publications
460 publications
- Date
- Relevance
-
Belimumab (Benlysta®) for the treatment of adult patients with auto-antibody-positive systemic lupus erythematosus (SLE)
The National Health Care Institute has carried out an assessment of the medicinal product subcutaneous belimumab (Benlysta®) and ...
-
Fampridine (Fampyra®) in cases of multiple sclerosis (MS)
The National Health Care Institute carried out an assessment of the medicinal product fampridine (Fampyra®). Based on the ...
-
Nusinersen (Spinraza®) for the treatment of 5q Spinal Muscular Atrophy
The National Health Care Institute carried out an assessment on the medicinal product nusinersen (Spinraza®) for the treatment ...
-
Evolocumab (Repatha®) for the treatment of hypercholeresterolaemia
The National Health Care Institute issued a package advice on the medicinal product evolocumab (Repatha®) for the treatment of ...
-
Cysteamine eyedrops (Cystadrops®) for the treatment of cystinosis
Zorginstituut Nederland carried out an assessment of the medicinal product cysteamine (Cystadrops®). The viscous cysteamine HCL ...
-
Zinnige Zorg room for improvement report - Chest pain (Suspected) Stable Angina Pectoris
The motto of the National Health Care Institute is "Taking care of good health care: no more and no less than necessary". Every ...
-
Zinnige Zorg room for improvement report - Appropriate use of expensive medicines in cases of metastatic renal cell carcinoma
Within the framework of the Zinnige Zorg Programme, Zorginstituut Nederland systematically assesses the Dutch minimal and ...
-
Idebenone (Raxone®) for the treatment of Leber’s Hereditary Optic Neuropathy (LHON)
The National Health Care Institute has carried out an assessment of the medicinal product idebenone (Raxone®). Idebenone ...
-
Programme ‘Outcome Information for Shared Decision-Making’ - factsheet
-
Project: ‘ICHOM as an accelerator for outcome information’ - factsheet